JPH0481964B2 - - Google Patents
Info
- Publication number
- JPH0481964B2 JPH0481964B2 JP60064204A JP6420485A JPH0481964B2 JP H0481964 B2 JPH0481964 B2 JP H0481964B2 JP 60064204 A JP60064204 A JP 60064204A JP 6420485 A JP6420485 A JP 6420485A JP H0481964 B2 JPH0481964 B2 JP H0481964B2
- Authority
- JP
- Japan
- Prior art keywords
- poe
- hydrophilic nonionic
- ether
- arbutin
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 claims description 23
- 239000002736 nonionic surfactant Substances 0.000 claims description 23
- 238000002360 preparation method Methods 0.000 claims description 13
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 42
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- -1 polyoxyethylene Polymers 0.000 description 13
- 229960000271 arbutin Drugs 0.000 description 11
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 11
- 239000006210 lotion Substances 0.000 description 9
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 7
- 239000004359 castor oil Substances 0.000 description 7
- 235000019438 castor oil Nutrition 0.000 description 7
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 7
- 229920001214 Polysorbate 60 Polymers 0.000 description 6
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 5
- 239000008346 aqueous phase Substances 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 229940058015 1,3-butylene glycol Drugs 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 125000003158 alcohol group Chemical group 0.000 description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 description 4
- 239000000600 sorbitol Substances 0.000 description 4
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 2
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 238000005063 solubilization Methods 0.000 description 2
- 230000007928 solubilization Effects 0.000 description 2
- 229940035044 sorbitan monolaurate Drugs 0.000 description 2
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- DXMNMEWATKSWOT-UHFFFAOYSA-N 1-[2,3-di(nonyl)phenoxy]-2,3-di(nonyl)benzene Chemical compound CCCCCCCCCC1=CC=CC(OC=2C(=C(CCCCCCCCC)C=CC=2)CCCCCCCCC)=C1CCCCCCCCC DXMNMEWATKSWOT-UHFFFAOYSA-N 0.000 description 1
- JPPRXACMNPYJNK-UHFFFAOYSA-N 1-docosoxydocosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCCCCCC JPPRXACMNPYJNK-UHFFFAOYSA-N 0.000 description 1
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 1
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 150000008151 D-glucosides Chemical class 0.000 description 1
- 125000002353 D-glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- WERKSKAQRVDLDW-ANOHMWSOSA-N [(2s,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO WERKSKAQRVDLDW-ANOHMWSOSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 125000000687 hydroquinonyl group Chemical group C1(O)=C(C=C(O)C=C1)* 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- ZPIRTVJRHUMMOI-UHFFFAOYSA-N octoxybenzene Chemical compound CCCCCCCCOC1=CC=CC=C1 ZPIRTVJRHUMMOI-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
- A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Description
[産業上の利用分野]
本発明は、親水性ノニオン界面活性剤特有のべ
たつきを抑えた皮膚外用剤に関する。
[従来の技術]
皮膚外用剤においては、可溶化、乳化、分散な
どの目的で界面活性剤が広く配合されている。と
くにノニオン界面活性剤は、皮膚や目に対する安
全性が良好で、しかも構造的にバラエテイーに富
んでいるので、被可溶化物、被乳化物あるいは被
分散物との構造的な相性や所要HLBにあわせて
所望のものを自由に選択できるので、界面活性剤
のなかでも最も頻繁に用いられるに至つている。
しかしながら、ノニオン界面活性剤のなかでも
親水性のものは、その親水基であるポリオキシエ
チレン(以下、POEと略称する)に起因する強
いべたつきを有している。このべたつきは、当然
のことながら、POE基が長くなるほどはなはだ
しくなり、さらには、配合成分中で界面活性が占
める割合の大きい化粧水などの系で顕著である。
[発明が解決しようとする問題点]
本発明者らはこのような事情にかんがみて親水
性ノニオン界面活性剤が有するべたつきを抑える
ことを目的に鋭意検討した結果、親水性ノニオン
界面活性剤ともに特定のハイドロキノンの配糖体
の特定量以上を配合すると、上記問題が解決する
ことを見いだし、本発明を完成するに至つた。
[問題点を解決するための手段]
すなわち、本発明はエチレンオキサイド(以下
EOという)含有の親水性ノニオン界面活性剤の
一種又は二種以上と、該親水性ノニオン界面活性
剤の5倍量(重量)以上のハイドロキノン−β−
D−グルコシド(一般名:アルブチン)とを含有
することを特徴とする皮膚外用剤である。
本発明で用いる親水性ノニオン界面活性剤は、
皮膚外用剤で使用される一般的な親水性ノニオン
界面活性剤を広く包含する。
べたつきを感じるポリオキシエチレン(以下
POEという)付加モル数は、おおよそ10モル付
加以上(界面活性剤のHLBで表せばHLB7以上
のノニオン界面活性剤がおおむねこれにあたる)
であり、150モル付加体位までが一般的である。
このような親水性ノニオン界面活性剤の具体例
を挙げるならば、たとえば、POEソルビタンモ
ノラウレート、POEソルビタンモノオレート、
POEソルビタンモノステアレート、POEソルビ
タンテトラオレートなどのPOEソルビタン脂肪
酸エステル、POEソルビツトモノラウレート、
POEソルビツトモノオレート、POEソルビツト
モノステアレート、POEソルビツトテトラオレ
ートなどPOEソルビツト脂肪酸エステル、POE
グリセリンモノステアレート、POEグリセリン
トリイソステアレートなどのPOEグリセリン脂
肪酸エステル、POEモノオレート、POEジステ
アレート、POEモノジオレートジステアリン酸
エチレングリコールなどのPOE脂肪酸エステル、
POEラウリルエーテル、POEオレイルエーテル、
POEベヘニルエーテル、POE2−オクチルドデシ
ルエーテル、POEコレスタノールエーテルなど
のPOEアルキルエーテル、POEオクチルフエニ
ルエーテル、POEジノニルフエニルエーテルな
どのPOEアルキルフエニルエーテル、POE・ポ
リオキシプロピレン(以下、POPと略称する)
エーテル、POE・POPセチルエーテル、POE・
POP2−デシルテトラデシルエーテル、POE・
POP水添ラノリン、POE・POPグリセリンエー
テルなどのPOE・POPアルキルエーテル、テト
ラPOE・テトラPOPエチレンジアミン縮合物、
POEヒマシ油、POE硬化ヒマシ油、POE硬化ヒ
マシ油モノイソステアレート、POE硬化ヒマシ
油トリイソスアレート、POE硬化ヒマシ油モノ
ピログルタミン酸モノイソステアリン酸ジエステ
ル、などのPOEヒマシ油誘導体、POEソルビツ
トミツロウなどのPOEミツロウ誘導体、POEラ
ノリン誘導体、POEプロピレングリコール脂肪
酸エステルなどである。
本発明においては、上記親水性ノニオン界面活
性剤の一種又は二種以上が任意に選ばれて用いら
れる。ハイドロキノンの配糖体が併用されない場
合のべたつきを感じる配合量は親水性ノニオン界
面活性剤の種類にも影響されるが、皮膚外用剤全
量中の0.1重量%以上程度であり、配合量の上限
は一般的には10重量%程度まで、好ましくは3重
量%以下である。
本発明において、親水性ノニオン界面活性剤と
ともに皮膚外用剤中に配合され、親水性ノニオン
界面活性剤のべたつきをおさえるハイドロキノン
の配糖体は下記一般式()で表される。
式()中RはD−グルコース残基であり、ハ
イドロキノンにβ結合している。
親水性ノニオン界面活性剤のべたつきをおさえ
るためには、上記アルブチンは親水性ノニオン界
面活性剤の種類にもよるが、おおむね親水性ノニ
オン界面活性剤の5倍量(重量)以上配合される
必要がある。好ましくは、皮膚外用剤全量中の6
〜20重量%の配合がよい。
親水性ノニオン界面活性剤および上記アルブチ
ンを配合できる皮膚外用剤は、通常の皮膚外用
剤、たとえば、水溶液系、可溶化系、乳化系、粉
末分散系、水−油2層系、水−油−粉末3層系な
ど、どのような基剤でもよく、用途も化粧水、乳
液、クリーム、パツクなどの基礎化粧料、口紅、
フアンデーシヨンなどのメーキヤツプ化粧料、シ
ヤンプー、リンス、ヘアトニツクなどの頭髪化粧
料などの化粧料、医薬部外品など多岐にわたる
が、なかでも、透明または半透明の化粧水に応用
したときにとくに真価を発揮する。化粧水は一般
に水−アルコールベースであり、また界面活性剤
の配合量が総配合物質量の大きい部分を占めるの
で、使用後のべたつきがとくに感じられるからで
ある。
本発明の皮膚外用剤には必要に応じて、本発明
の効果を損なわない範囲で、保湿剤、増粘剤、防
腐剤、酸化防止剤、金属イオン封鎖剤、紫外線吸
収剤、粉末、顔料、薬剤、色素、香料などを配合
できる。
[発明の効果]
本発明の皮膚外用剤は、親水性ノニオン界面活
性剤特有のべたつきがなく、かつ安定性、安全性
も良好な優れた皮膚外用剤である。
[実施例]
つぎに実施例により本発明をさらに詳細に説明
する。本発明は、これによつて何ら限定されるも
のではない。
実施例 1
化粧水
エタノール 20.0
1,3−ブチレングリコール 5.0
POE(15)オレイルエーテル 1.0
エチルパラベン 0.1
アルブチン 6.0
精製水 残余
(製法)
エタノールの一部にPOEオレイルエーテルお
よびエチルパラベンを溶解する。別に精製水とエ
タノールの残部に1,3−ブチレングリコールお
よびアルブチンを溶解する。エタノール相を水相
中に添加、可溶化して化粧水を得た。
比較例 1
実施例1のアルブチンを3.0重量%に減量した
他は実施例1に準じて、比較例1を得た。
比較例 2
実施例1のアルブチンを1.0重量%に減量した
他は実施例1に準じて、比較例2を得た。
実施例1、比較例1〜2の使用性(べたつき)
を、女性美容専門パネルの実使用試験によつて判
定、評価した。
(判定)
A;べたつかない。
B;わずかにべたつくが、使用性上問題のない範
囲である。
C;べたつく。
D;著しくべたつく。
結果を表−1に示す。
アルブチンが、親水性ノニオン界面活性剤のべ
たつきを防止し、とくに6重量%以上で有効なこ
とがが明らかである。
[Industrial Field of Application] The present invention relates to an external skin preparation that suppresses the stickiness characteristic of hydrophilic nonionic surfactants. [Prior Art] In skin preparations for external use, surfactants are widely blended for purposes such as solubilization, emulsification, and dispersion. In particular, nonionic surfactants are safe for the skin and eyes, and have a wide variety of structures. In addition, since it is possible to freely select the desired surfactant, it has become the most frequently used surfactant. However, among nonionic surfactants, hydrophilic ones have strong stickiness due to their hydrophilic group, polyoxyethylene (hereinafter abbreviated as POE). Naturally, this stickiness becomes more pronounced as the POE group becomes longer, and it is more noticeable in systems such as lotions where surface activity accounts for a large proportion of the ingredients. [Problems to be Solved by the Invention] In view of the above circumstances, the present inventors conducted extensive studies aimed at suppressing the stickiness of hydrophilic nonionic surfactants, and as a result, they identified both hydrophilic nonionic surfactants. It has been found that the above problem can be solved by blending a specific amount or more of the glycoside of hydroquinone, and the present invention has been completed. [Means for solving the problems] That is, the present invention uses ethylene oxide (hereinafter referred to as ethylene oxide).
EO) containing one or more hydrophilic nonionic surfactants and hydroquinone-β- in an amount (by weight) or more 5 times that of the hydrophilic nonionic surfactant.
This is an external skin preparation characterized by containing D-glucoside (generic name: arbutin). The hydrophilic nonionic surfactant used in the present invention is
It broadly includes general hydrophilic nonionic surfactants used in external skin preparations. Polyoxyethylene (below) that feels sticky
The number of moles added (called POE) is approximately 10 moles or more (nonionic surfactants with HLB of 7 or more correspond to this in terms of HLB of surfactants)
and up to 150 molar adduct positions are common. Specific examples of such hydrophilic nonionic surfactants include POE sorbitan monolaurate, POE sorbitan monooleate,
POE sorbitan fatty acid esters such as POE sorbitan monostearate, POE sorbitan tetraoleate, POE sorbitan monolaurate,
POE sorbitol fatty acid esters, POE sorbitol monooleate, POE sorbitol monostearate, POE sorbitol tetraoleate, POE
POE glycerin fatty acid esters such as glycerin monostearate, POE glycerin triisostearate, POE fatty acid esters such as POE monooleate, POE distearate, POE monodiolate ethylene glycol distearate,
POE lauryl ether, POE oleyl ether,
POE alkyl ethers such as POE behenyl ether, POE2-octyldodecyl ether, and POE cholestanol ether; POE alkyl phenyl ethers such as POE octyl phenyl ether and POE dinonyl phenyl ether; abbreviated)
Ether, POE/POP cetyl ether, POE/
POP2-decyltetradecyl ether, POE・
POP hydrogenated lanolin, POE/POP alkyl ether such as POE/POP glycerin ether, tetraPOE/tetraPOP ethylenediamine condensate,
POE castor oil derivatives such as POE castor oil, POE hydrogenated castor oil, POE hydrogenated castor oil monoisostearate, POE hydrogenated castor oil triisostearate, POE hydrogenated castor oil monopyroglutamic acid monoisostearate diester, POE sorbitol beeswax These include POE beeswax derivatives, POE lanolin derivatives, and POE propylene glycol fatty acid esters. In the present invention, one or more of the above hydrophilic nonionic surfactants are arbitrarily selected and used. When hydroquinone glycosides are not used in combination, the amount at which stickiness is felt is influenced by the type of hydrophilic nonionic surfactant, but it is approximately 0.1% by weight or more of the total amount of the skin external preparation, and the upper limit of the amount is It is generally up to about 10% by weight, preferably up to 3% by weight. In the present invention, a hydroquinone glycoside that is blended into a skin external preparation together with a hydrophilic nonionic surfactant to suppress the stickiness of the hydrophilic nonionic surfactant is represented by the following general formula (). In formula (), R is a D-glucose residue, which is β-bonded to hydroquinone. In order to suppress the stickiness of the hydrophilic nonionic surfactant, the above-mentioned arbutin needs to be blended in an amount at least 5 times the amount (weight) of the hydrophilic nonionic surfactant, although it depends on the type of the hydrophilic nonionic surfactant. be. Preferably, 6 in the total amount of the skin external preparation.
A good blend is ~20% by weight. The skin external preparations that can contain the hydrophilic nonionic surfactant and the above-mentioned arbutin include the usual skin external preparations, such as aqueous solutions, solubilized systems, emulsification systems, powder dispersion systems, water-oil two-layer systems, water-oil- Any type of base may be used, such as a three-layer powder type, and can be used in basic cosmetics such as lotions, milky lotions, creams, and packs, lipsticks,
There are a wide variety of cosmetics, including makeup cosmetics such as foundation, hair cosmetics such as shampoo, conditioner, and hair tonic, and quasi-drugs, but their true value is especially true when applied to transparent or translucent lotions. demonstrate. This is because lotions are generally water-alcohol based, and the amount of surfactant added accounts for a large portion of the total amount of ingredients, so they tend to feel particularly sticky after use. The external skin preparation of the present invention may contain moisturizers, thickeners, preservatives, antioxidants, sequestering agents, ultraviolet absorbers, powders, pigments, etc., as necessary, to the extent that the effects of the present invention are not impaired. Drugs, dyes, fragrances, etc. can be added. [Effects of the Invention] The skin external preparation of the present invention is an excellent skin external preparation that does not have the stickiness characteristic of hydrophilic nonionic surfactants and has good stability and safety. [Example] Next, the present invention will be explained in more detail with reference to Examples. The present invention is not limited to this in any way. Example 1 Toner lotion ethanol 20.0 1,3-butylene glycol 5.0 POE(15) oleyl ether 1.0 ethyl paraben 0.1 arbutin 6.0 Purified water Remainder (manufacturing method) POE oleyl ether and ethyl paraben are dissolved in a portion of ethanol. Separately, 1,3-butylene glycol and arbutin are dissolved in the remaining purified water and ethanol. The ethanol phase was added to the aqueous phase and solubilized to obtain a lotion. Comparative Example 1 Comparative Example 1 was obtained according to Example 1 except that the amount of arbutin in Example 1 was reduced to 3.0% by weight. Comparative Example 2 Comparative Example 2 was obtained according to Example 1 except that the amount of arbutin in Example 1 was reduced to 1.0% by weight. Usability (stickiness) of Example 1 and Comparative Examples 1 and 2
were determined and evaluated through actual use tests conducted by a panel specializing in women's beauty. (Judgment) A: Not sticky. B: Slightly sticky, but within a range that poses no problem in terms of usability. C: Sticky. D: Significantly sticky. The results are shown in Table-1. It is clear that arbutin prevents the stickiness of the hydrophilic nonionic surfactant and is particularly effective at 6% by weight or more.
【表】
実施例 2
化粧水
(A) 精製水 全体が100になる量
グリセリン 2.0
アルブチン 1.0
1,3−ブチレングリコール 2.0
(B) エタノール 15.0
精製レシチン 0.02
POE(120)硬化ヒマシ油 0.2
香 料 0.05
メチパラベン 0.1
(製法)
(A)の水相部及び(B)のアルコール部をそれぞれ均
一溶解した後、水相部にアルコール部を加えて可
溶化し、化粧水を得た。
実施例 3
水性エツセンス
(A) 精製水 全体が100になる量
1,3−ブチレングリコール 10.0
マルチトール 2.0
アルブチン 10.0
ジプロピレングリコール 5.0
カルボキシメチルポリマー 0.2
(B) エタノール 10.0
POE(20)グリセリンモノイソステアレート 1.0
ビタミンEアセテート 0.1
香 料 0.05
オレイルアルコール 0.2
メチルパラベン 0.2
(C) 水酸化ナトリウム 0.1
(製法)
(A)の水相部及び(B)のアルコール部をそれぞれ均
一溶解した後、水相部にアルコール部を加えて混
合可溶化し、ついで(C)の水酸化カリウムを加えて
エツセンスを得た。
実施例 4
クリーム軟こう
ワセリン 20.0
ステアリルアルコール 15.0
モクロウ 15.0
POE(20)・POE(10) 1.0
ステアリン酸モノグリセリド 1.0
アルブチン 6.0
エタノール 10.0
精製水 残余[Table] Example 2 Lotion (A) Purified water Amount to make the total 100 Glycerin 2.0 Arbutin 1.0 1,3-butylene glycol 2.0 (B) Ethanol 15.0 Purified lecithin 0.02 POE (120) Hydrogenated castor oil 0.2 Fragrance 0.05 Methyparaben 0.1 (Production method) After uniformly dissolving the aqueous phase part (A) and the alcohol part (B), the alcohol part was added to the aqueous phase part for solubilization to obtain a lotion. Example 3 Aqueous essence (A) Purified water 1,3-butylene glycol 10.0 Maltitol 2.0 Arbutin 10.0 Dipropylene glycol 5.0 Carboxymethyl polymer 0.2 (B) Ethanol 10.0 POE (20) Glycerin monoisostearate 1.0 Vitamin E acetate 0.1 Fragrance 0.05 Oleyl alcohol 0.2 Methyl paraben 0.2 (C) Sodium hydroxide 0.1 (Production method) After uniformly dissolving the aqueous phase part of (A) and the alcohol part of (B), add the alcohol part to the aqueous phase part. was added to mix and solubilize, and then potassium hydroxide (C) was added to obtain essence. Example 4 Cream ointment Vaseline 20.0 Stearyl alcohol 15.0 Mokuro 15.0 POE(20)・POE(10) 1.0 Stearic acid monoglyceride 1.0 Arbutin 6.0 Ethanol 10.0 Purified water Residual
Claims (1)
面活性剤の一種又は二種以上と、該親水性ノニオ
ン界面活性剤の5倍量(重量)以上のハイドロキ
ノン−β−D−グルコシドを含有することを特徴
とする皮膚外用剤。1. It is characterized by containing one or more hydrophilic nonionic surfactants containing ethylene oxide and hydroquinone-β-D-glucoside in an amount (by weight) or more five times that of the hydrophilic nonionic surfactant. External skin preparation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6420485A JPS61221106A (en) | 1985-03-28 | 1985-03-28 | Epidermic preparation for external use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6420485A JPS61221106A (en) | 1985-03-28 | 1985-03-28 | Epidermic preparation for external use |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS61221106A JPS61221106A (en) | 1986-10-01 |
JPH0481964B2 true JPH0481964B2 (en) | 1992-12-25 |
Family
ID=13251302
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6420485A Granted JPS61221106A (en) | 1985-03-28 | 1985-03-28 | Epidermic preparation for external use |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS61221106A (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2557657B2 (en) * | 1987-08-28 | 1996-11-27 | エスエス製薬株式会社 | Transdermal absorption promoting base composition |
IT1254995B (en) * | 1992-06-24 | 1995-10-11 | DRUG CONTAINING MELATONIN AND / OR AGONISTS, WITH PARTICULARLY EFFECTIVE ADMINISTRATION IN PATHOLOGIES THAT INTERFER WITH CIRCANDIAN RHYTHMS | |
FR2754454B1 (en) * | 1996-10-10 | 1998-11-27 | Oreal | USE OF AT LEAST ONE GLYCOL AS A SOLUBILIZING AGENT FOR MELATONIN IN WATER AND COMPOSITIONS OBTAINED |
JP2004189717A (en) * | 2002-11-27 | 2004-07-08 | Shiseido Co Ltd | Hair dye composition |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6016906A (en) * | 1983-07-07 | 1985-01-28 | Pola Chem Ind Inc | External drug for skin |
-
1985
- 1985-03-28 JP JP6420485A patent/JPS61221106A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS61221106A (en) | 1986-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100423458B1 (en) | External skin preparation | |
JP3657395B2 (en) | Composition for external use | |
US5310556A (en) | Cosmetic composition | |
EP1418884A2 (en) | Cosmetic and dermatological preparations in the form of o/w emulsions containing sterols and/or c12-c40 fatty acids | |
EP0985404A1 (en) | Oil-in-water type emulsified compositions | |
JP3344822B2 (en) | External preparation for skin | |
JP2003526602A (en) | Cosmetic and dermatological preparations comprising an effective amount of bile acids, their salts and / or their derivatives | |
JP3524717B2 (en) | Water-in-oil emulsion composition and emulsified cosmetic using the same | |
JPH08133952A (en) | Skin preparation for external use | |
JPH0481964B2 (en) | ||
JP3849958B2 (en) | Topical skin preparation | |
CN112741781A (en) | Transparent oil solution of water-oil insoluble licoflavone, and its preparation method and application | |
JPH08133948A (en) | Skin preparation for external use | |
JPH01100114A (en) | External preparation for skin | |
JPH0415763B2 (en) | ||
KR102646279B1 (en) | A composition having improved emulsion stability comprising hydroquinone | |
JP3675637B2 (en) | Composition for external use | |
JP2720247B2 (en) | External preparation for skin | |
JPH1171262A (en) | Cosmetic | |
JP3234041B2 (en) | External preparation for skin | |
JP2003313107A (en) | Cosmetic composition comprising ginseng saponins | |
JPH08268866A (en) | Dermal preparation for external use | |
WO2023157851A1 (en) | Transparent aqueous composition | |
JP5238139B2 (en) | Liquid emulsified cosmetic | |
KR20010014650A (en) | An antiseptic/antifungal agent and an endermic liniment composition containing same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |